BI-1910 is a human monoclonal antibody (mAb) targeting TNFRSF1B. It enhances T cell activation and induces CD8 T cell-dependent anti-tumor activity. BI-1910 is applicable for research on solid tumors. Recommended isotype control: HumanIgG1lambda, Isotype Control.
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted